Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAmitriptyline and Mounjaro can be taken alongside each other, but the combination deserves a careful look from your prescriber before treatment starts. Mounjaro (tirzepatide) slows gastric emptying, which can change how quickly other medicines reach your bloodstream — and amitriptyline, a tricyclic antidepressant, is sensitive to that kind of timing shift. No specific interaction has been added to Mounjaro's UK prescribing information banning the two together, but the possibility that tirzepatide alters amitriptyline absorption is clinically relevant enough that your prescriber needs to know about every medicine you take. These are prescription-only medicines; a GPhC-registered clinician assesses the full picture before anything is prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's primary mechanism as a dual GIP and GLP-1 receptor agonist involves slowing the rate at which the stomach empties its contents into the small intestine. For most people this is part of what reduces appetite. For someone also taking an oral medicine like amitriptyline, the practical consequence is that the drug may spend longer in the stomach before being absorbed, meaning peak blood levels arrive later than they normally would.
Whether that delay is clinically significant depends on the dose, the individual's metabolism and how stable their amitriptyline level already is. In some people a modest delay is imperceptible. In others, particularly those whose antidepressant dose has been carefully titrated over time, even a modest shift in absorption could affect mood, pain control (amitriptyline is widely used for neuropathic pain and migraine prevention) or side-effect burden.
The NHS medicines page for tirzepatide advises that Mounjaro can affect the absorption of other oral medicines and that this should be discussed with a prescriber. The Mounjaro SmPC on the eMC echoes this, noting that the delay in gastric emptying has the potential to influence co-administered oral drugs. Neither source lists amitriptyline by name as contraindicated, the point is that the class effect of slowed emptying applies broadly to oral medicines.
A prescriber's job, before approving tirzepatide for anyone already on amitriptyline, is to weigh that picture specifically for them. That conversation is worth having rather than skipping.
The gastric-emptying question is the most discussed, but it is not the only angle worth considering. Amitriptyline at therapeutic doses has anticholinergic activity, it can itself slow gut motility and contribute to constipation. Mounjaro's side-effect profile is GI-led: nausea, constipation and indigestion are among the most commonly reported effects in clinical trials and in real-world use. Layering two medicines that both slow gut transit increases the likelihood that GI side effects feel more pronounced, at least in the early weeks of treatment.
Amitriptyline can also have cardiac effects at higher doses, including changes to heart rate. While tirzepatide does not carry a primary cardiac warning in its UK label for the weight-management indication, people taking regular doses of a tricyclic antidepressant are more likely to have their overall health profile reviewed carefully before any new prescription-only treatment is added.
Weight change itself can alter how amitriptyline behaves. The medicine is distributed into fatty tissue, so significant fat loss over months of treatment could, in theory, affect the way the body handles it. Again, this is a reason for regular prescriber check-ins rather than a reason to avoid tirzepatide, but it is a reason the check-ins matter. The BNF entry for tirzepatide notes the potential for interactions with other oral medicines through this mechanism.
If you are also prescribed amitriptyline for pain rather than depression, it is worth telling whoever manages that prescription that you are considering or starting Mounjaro. The two conversations do not always happen in the same room.
For many people the answer is yes, the two can be used together under appropriate supervision. The absence of a formal contraindication in the UK label is meaningful: it means the evidence base reviewed by the MHRA at approval did not identify a categorical bar. What it does not mean is that the combination is always straightforward or that no monitoring is needed.
In practice, a prescriber considering tirzepatide for someone already stable on amitriptyline would typically want to know the amitriptyline dose, what it is being used for, and how recently the dose was last adjusted. They might flag that GI side effects could feel stronger initially, and they would want the person to report any change in mood, pain levels or cardiac symptoms promptly. Some people taking long-term amitriptyline have occasional ECG monitoring; that is worth mentioning too.
At nume, a named GPhC-registered Independent Prescriber reads every consultation personally on the day it is submitted. Medicines lists are a core part of that review, not a box-ticking exercise. People who list amitriptyline will have that fact considered in the clinical decision, not filtered out by software. You can learn more about how our clinical team approaches these assessments on our clinical lead's profile page.
If you have questions about your specific situation before committing to a consultation, the faqs page covers common scenarios, and our aftercare team is available seven days a week via the contact page.
The first step is straightforward: list amitriptyline on your consultation form and note the dose and what it is prescribed for. Do not omit it on the assumption it is unrelated to weight management. Every medicine you take regularly belongs on that list, including over-the-counter analgesics and supplements, because gastric-emptying effects apply broadly to oral medicines regardless of their class.
It is also worth letting your GP know you are considering or have started tirzepatide if they are the one managing your amitriptyline prescription. That keeps both clinicians informed and reduces the risk of one changing a dose without the other knowing. Mounjaro's prescribing information specifically recommends that the prescriber is aware of all concurrent medicines.
Timing of doses can become relevant too. Some oral medicines are better absorbed if taken at a point in the dosing week when Mounjaro's effect on gastric emptying is at its lowest, typically in the days furthest from the injection. This is not a standardised protocol but is an area your prescriber can advise on for your specific situation. People who want to explore whether Mounjaro on line is an option that suits their circumstances will find the process explained clearly, including how injection timing fits into a weekly routine. The timing of your amitriptyline relative to that is a sensible thing to raise.
There is a separate but related question that sometimes comes up around other medicines taken alongside Mounjaro, including antidepressants that affect serotonin pathways. The interaction profile for sertraline, for instance, differs from amitriptyline's, if that is relevant to you, the page on Mounjaro and sertraline covers that ground specifically. For a broader picture of what to expect from the medicine before getting into combination questions, the Mounjaro overview is a good starting point, and if cost is a consideration the Mounjaro price comparison page gives honest UK context. The tirzepatide clinical overview covers the mechanism in more depth for anyone who wants the science behind how it works.
If you are ready to find out whether getting Mounjaro online is clinically suitable for you given your current medicines, check your eligibility with a free consultation, reviewed the same day by a real prescriber, not an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.